[1] |
Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73(1): 17-48.
|
[2] |
中华人民共和国国家卫生健康委员会, 中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2023年版)[J]. 中华外科杂志, 2023, 61(8): 617-644.
|
[3] |
Benson AB, Venook AP, Al-Hawary MM, et al. Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2022, 20(10): 1139-1167.
|
[4] |
Zhuang CL, Zhang FM, Wang Z, et al. Precision functional sphincter-preserving surgery(PPS) for ultralow rectal cancer: a natural orifice specimen extraction (NOSE) surgery technique[J]. Surg Endosc, 2021, 35(1): 476-485.
|
[5] |
庄成乐, 刘正, 张锋敏, 等. 经自然腔道取标本手术之精准功能保肛术操作要点[J]. 中华胃肠外科杂志, 2020, 23(6): 597-600.
|
[6] |
庄成乐, 张现中, 刘骞, 等. 基于一种螺纹扩肛器的超低位直肠癌精准保肛(PPS)手术[J/CD]. 中华结直肠疾病电子杂志, 2019, 8(5): 509-512.
|
[7] |
庄成乐, 刘正, 张锋敏, 等. 基于精准吻合器和刘氏吻合三步法的改良PPS术与传统PPS术治疗超低位直肠癌的非随机病例对照临床研究[J/OL]. 中华结直肠疾病电子杂志, 2022, 11(1): 30-35.
|
[8] |
Atasoy G, Arslan NC, Elibol FD, et al. Magnetic resonance-based pelvimetry and tumor volumetry can predict surgical difficulty and oncologic outcome in locally advanced mid-low rectal cancer[J]. Surg Today, 2018, 48(12): 1040-1051.
|
[9] |
Ferko A, Malý O, Örhalmi J, et al. CT/MRI pelvimetry as a useful tool when selecting patients with rectal cancer for transanal total mesorectal excision[J]. Surg Endosc, 2016, 30(3): 1164-1171.
|
[10] |
Zhou XC, Su M, Hu KQ, et al. CT pelvimetry and clinicopathological parameters in evaluation of the technical difficulties in performing open rectal surgery for mid-low rectal cancer[J]. Oncol Lett, 2016, 11(1): 31-38.
|
[11] |
Lee JM, Han YD, Cho MS, et al. Prediction of transabdominal total mesorectal excision difficulty according to the angle of pelvic floor muscle[J]. Surg Endosc, 2020, 34(7): 3043-3050.
|
[12] |
Lirici MM, Hüscher CG. Techniques and technology evolution of rectal cancer surgery: a history of more than a hundred years[J]. Minim Invasive Ther Allied Technol, 2016, 25(5): 226-233.
|
[13] |
Kang L, Zeng Z, Luo S, et al. Transanal vs laparoscopic total mesorectal excision for rectal cancer: a multicenter randomized phase III clinical trial (TaLaR trial) protocol[J]. Gastroenterol Rep (Oxf), 2020, 9(1): 71-76.
|
[14] |
Ogiso S, Yamaguchi T, Hata H, et al. Evaluation of factors affecting the difficulty of laparoscopic anterior resection for rectal cancer: "narrow pelvis" is not a contraindication[J]. Surg Endosc, 2011, 25(6): 1907-1912.
|
[15] |
Baik SH, Kim NK, Lee KY, et al. Factors influencing pathologic results after total mesorectal excision for rectal cancer: analysis of consecutive 100 cases[J]. Ann Surg Oncol, 2008, 15(3): 721-728.
|
[16] |
Targarona EM, Balague C, Pernas JC, et al. Can we predict immediate outcome after laparoscopic rectal surgery? Multivariate analysis of clinical, anatomic, and pathologic features after 3-dimensional reconstruction of the pelvic anatomy[J]. Ann Surg, 2008, 247(4): 642-649.
|
[17] |
Yamaoka Y, Yamaguchi T, Kinugasa Y, et al. Mesorectal fat area as a useful predictor of the difficulty of robotic-assisted laparoscopic total mesorectal excision for rectal cancer[J]. Surg Endosc, 2019, 33(2): 557-566.
|